Long-term outcome among men with conservatively treated localised prostate cancer

British Journal of Cancer

Volumn 95, Issue 9, 2006, Pages 1186-1194

  Cuzick, J ^a   Fisher, G ^a   Kattan, M W ^b   Berney, D ^c   Oliver, T ^c   Foster, C S ^d   Moller H ^e   Reuter, V ^f   Fearn, P ^f   Eastham, J ^f   Scardino, P ^f  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Localised prostate cancer; Prognostic factors

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; GLEASON SCORE; HUMAN; LONG TERM CARE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; UNITED KINGDOM;

AGED; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33750455445     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603411     Document Type: Article

References (17)

1. Adolfsson J, Steineck G, Hedlund P-O (1997) Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series. Urology 50: 722-726
2. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1995) Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626-631
3. Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, Fine J (2005a) Cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97: 1248- 1253
4. Albertsen P, Hanley JA, Fine J (2005b) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293: 2095-2101
5. Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280: 975-980
6. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlen BJ, Johansson JE, Scandinavian Prostate Cancer Group Study No. 4 (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352: 1977-1984
7. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H (1977) Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 20: 680-688
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40: 373-383
9. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, Chisholm GD, Moskovitz B, Livne PM, Warner J (1994) Results of conservative management of clinically localized prostate cancer. N Engl J Med 330: 242-248
10. Deshmukh N, Foster CS (1997) Grading prostate cancer. In Pathology of the Prostate Foster CS, Bostwick DG (eds) pp 191-227. Philadelphia: WB Saunders
11. Evans MS, Møller H (2003) Recent trends in prostate cancer incidence and mortality in Southeast England. Eur Urol 43: 337-341
12. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, Andersson SO, Spangberg A, Busch C, Nordling S, Palmgren J, Adami HO, Johansson JE, Norlen BJ, Scandinavian Prostatic Cancer Group Study Number (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347: 781-789
13. Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, Adami HO (2004) Natural history of early, localized prostate cancer. JAMA 291: 2713-2719
14. Kattan MW, Eastham JA, Stapleton AMF, Wheeler TM, Scardino PT (1998) A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90: 766-771
15. Kondylis FI, Moriarty RP, Bostwick D, Schellhammer PF (2003) Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias. J Urol 170: 1189-1193
16. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In vivo 8: 439-443
17. Satariano WA, Ragland KE, Van Den Eeden SK (1998) Cause of death in men diagnosed with prostate cancer. Cancer 83: 1180-1188